P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biochemistry

• Publication date

  2008-09-23

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/bi800209hPMID 18759452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of Size and Charge for Blood–Brain Barrier Permeation of Drugs and Fatty Acids

  2007cited by this paper
• P-Glycoprotein kinetics measured in plasma membrane vesicles and living cells.

  2007cited by this paper
• Quantification and characterization of P-glycoprotein-substrate interactions.

  2006cited by this paper
• Thermodynamics of the ATPase cycle of GlcV, the nucleotide-binding domain of the glucose ABC transporter of sulfolobus solfataricus.

  2006cited by this paper
• Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding

  2006cited by this paper
• Suppression of Na+/K+-ATPase activity during estivation in the land snail Otala lactea

  2006cited by this paper
• Interaction of verapamil with lipid membranes and P-glycoprotein: connecting thermodynamics and membrane structure with functional activity.

  2006cited by this paper
• Defeating drug resistance in cancer.

  2006cited by this paper
• Inhibitors of multidrug efflux transporters: their membrane and protein interactions.

  2005cited by this paper
• Three-dimensional Structure of P-glycoprotein

  2005cited by this paper
• The rate of P-glycoprotein activation depends on the metabolic state of the cell.

  2004cited by this paper
• The role of ABC transporters in drug resistance, metabolism and toxicity.

  2004cited by this paper
• The ATP switch model for ABC transporters

  2004cited by this paper
• Improved energy coupling of human P-glycoprotein by the glycine 185 to valine mutation.

  2004cited by this paper
• Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein*

  2003cited by this paper
• Peptides Induce ATP Hydrolysis at Both Subunits of the Transporter Associated with Antigen Processing*

  2003cited by this paper
• Transition state P-glycoprotein binds drugs and modulators with unchanged affinity, suggesting a concerted transport mechanism.

  2003cited by this paper
• Interactions of cyclosporines with lipid membranes as studied by solid-state nuclear magnetic resonance spectroscopy and high-sensitivity titration calorimetry.

  2002cited by this paper
• A Novel Electron Paramagnetic Resonance Approach to Determine the Mechanism of Drug Transport by P-glycoprotein*

  2002cited by this paper
• Allosteric crosstalk between peptide-binding, transport, and ATP hydrolysis of the ABC transporter TAP

  2001cited by this paper
• Correlation between Steady-state ATP Hydrolysis and Vanadate-induced ADP Trapping in Human P-glycoprotein

  2001cited by this paper
• Functionally Similar Vanadate-induced 8-Azidoadenosine 5′-[α-32P]Diphosphate-trapped Transition State Intermediates of Human P-glycoprotein Are Generated in the Absence and Presence of ATP Hydrolysis*

  2001cited by this paper
• Modulation of Na,K-ATPase and Na-ATPase activity by phospholipids and cholesterol. I. Steady-state kinetics.

  2001cited by this paper
• Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state.

  2001cited by this paper
• Characterization of the Catalytic Cycle of ATP Hydrolysis by Human P-glycoprotein

  2001cited by this paper
• Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison.

  2000cited by this paper
• Co-operating ATP sites in the multiple drug resistance transporter Mdr1.

  1999cited by this paper
• Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies.

  1999cited by this paper
• Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion

  1998cited by this paper
• A general pattern for substrate recognition by P-glycoprotein.

  1998cited by this paper
• The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids.

  1998cited by this paper
• Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity.

  1997cited by this paper
• Relation Between the Turnover Number for Vinblastine Transport and for Vinblastine-stimulated ATP Hydrolysis by Human P-glycoprotein*

  1997cited by this paper
• Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein.

  1997cited by this paper
• The catalytic cycle of P‐glycoprotein

  1995cited by this paper
• Evaluation of the rate constants of sugar transport through maltoporin (LamB) of Escherichia coli from the sugar-induced current noise

  1995cited by this paper
• The lipids of slugs and snails: Evolution, diet and biosynthesis

  1994cited by this paper
• Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein.

  1993cited by this paper
• The effects of lipids and detergents on ATPase-active P-glycoprotein.

  1993cited by this paper
• Interaction of a substance P agonist and of substance P antagonists with lipid membranes. A thermodynamic analysis.

  1992cited by this paper
• Nonclassical hydrophobic effect in membrane binding equilibria.

  1991cited by this paper
• Electrogenic ion pumps

  1991cited by this paper
• Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells.

  1990cited by this paper
• Lipid fluidity directly modulates the overall protein rotational mobility of the Ca-ATPase in sarcoplasmic reticulum.

  1988cited by this paper
• Interactions of the local anesthetic tetracaine with membranes containing phosphatidylcholine and cholesterol: a 2H NMR study.

  1988cited by this paper
• Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers.

  1987cited by this paper
• Effect of a single cis double bond on the structures of a phospholipid bilayer.

  1977cited by this paper

• Drug-bound P-glycoprotein reveals nucleotide-dependent ligand pockets and ingress channels

  2025cites this paper
• Role of Hypoxia-Associated Long Noncoding RNAs in Cancer Chemo-Therapy Resistance

  2025cites this paper
• P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

  2023cites this paper
• Ligand’s Partition to the Lipid Bilayer Should Be Accounted for When Estimating Their Affinity to Proteins

  2023cites this paper
• Interaction of a Homologous Series of Amphiphiles with P-glycoprotein in a Membrane Environment—Contributions of Polar and Non-Polar Interactions

  2023cites this paper
• Extracellular Alterations in pH and K+ Modify the Murine Brain Endothelial Cell Total and Phospho-Proteome

  2022cites this paper
• Effects of Polyphenols on P-Glycoprotein (ABCB1) Activity

  2021cites this paper
• Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington's Disease

  2020cites this paper
• Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance

  2020cites this paper
• Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?

  2017cites this paper
• Blood-Brain Barrier and Cognitive Function

  2017cites this paper
• Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein

  2017cites this paper
• About P‐glycoprotein: a new drugable domain is emerging from structural data

  2017cites this paper
• P-glycoprotein and membrane roles in multidrug resistance.

  2015cites this paper
• Interaction of the P-Glycoprotein Multidrug Transporter with Sterols.

  2015cites this paper
• Do adsorbed drugs onto P-glycoprotein influence its efflux capability?

  2015cites this paper
• Effects of nucleotide binding to LmrA: A combined MAS-NMR and solution NMR study.

  2015cites this paper
• Reversing cancer multidrug resistance: insights into the efflux by ABC transports from in silico studies

  2015cites this paper
• Interactions of anticancer drugs with biomembranes: what can we learn from model membranes?

  2014cites this paper
• Multidrug Resistance Protein

  2014cites this paper
• Integrated Approach to Optimizing CNS Penetration in Drug Discovery: From the Old to the New Paradigm and Assessment of Drug–Transporter Interactions

  2014cites this paper
• Anatomy and Physiology of the Blood–Brain Barriers

  2014cites this paper
• Structure–Function of Plant ABC-Transporters

  2014cites this paper
• Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function

  2014cites this paper
• Drug Delivery to the Brain

  2014cites this paper
• Can long range mechanical interaction between drugs and membrane proteins define the notion of molecular promiscuity? Application to P-glycoprotein-mediated multidrug resistance (MDR).

  2013cites this paper
• Sav1866 from Staphylococcus aureus and P-glycoprotein: similarities and differences in ATPase activity assessed with detergents as allocrites.

  2013cites this paper
• Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.

  2013cites this paper
• Lipid bilayer properties control membrane partitioning, binding, and transport of p-glycoprotein substrates.

  2013cites this paper
• In-silico models for the characterization of compounds interfering with clinical relevant ABC-multidrug-transporters

  2013cites this paper
• How hydrogen bonds impact P-glycoprotein transport and permeability.

  2012cites this paper
• P-glycoprotein-ATPase modulation: the molecular mechanisms.

  2012cites this paper
• On the interaction of cationic compounds with ABC-transporters and lipid membranes

  2012cites this paper
• Overview and introduction: The blood–brain barrier in health and disease

  2012influential citation
• Comparison of NMR lipid profiles in mitotic arrest and apoptosis as indicators of paclitaxel resistance in cervical cell lines

  2012cites this paper
• Full efficacy with no CNS side-effects: unachievable panacea or reality? DMPK considerations in design of drugs with limited brain penetration

  2012cites this paper
• The Role of the Lipid Bilayer in P-glycoprotein Drug Binding, Transport and Catalytic Functions

  2011cites this paper
• Fitting the Elementary Rate Constants of the P-gp Transporter Network in the hMDR1-MDCK Confluent Cell Monolayer Using a Particle Swarm Algorithm

  2011cites this paper
• Impact of the Recent Mouse P‐Glycoprotein Structure for Structure‐Based Ligand Design

  2010cites this paper
• The structure and functions of P-glycoprotein.

  2010cites this paper
• Optimization of transversal relaxation of nitroxides for pulsed electron-electron double resonance spectroscopy in phospholipid membranes.

  2010cites this paper
• P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activity.

  2010cites this paper
• Multidrug efflux pumps: drug binding – gates or cavity?

  2010cites this paper
• Detergents as intrinsic P-glycoprotein substrates and inhibitors.

  2009cites this paper
• Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity.

  2009cites this paper